- Home
- ULCC vs OCUL Comparison
ULCC vs OCUL Comparison
Compare ULCC & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULCC
- OCUL
- Stock Information
- Founded
- ULCC 1994
- OCUL 2006
- Country
- ULCC United States
- OCUL United States
- Employees
- ULCC N/A
- OCUL N/A
- Industry
- ULCC Air Freight/Delivery Services
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- ULCC Consumer Discretionary
- OCUL Health Care
- Exchange
- ULCC Nasdaq
- OCUL Nasdaq
- Market Cap
- ULCC 1.5B
- OCUL 1.4B
- IPO Year
- ULCC 2021
- OCUL 2014
- Fundamental
- Price
- ULCC $5.55
- OCUL $8.52
- Analyst Decision
- ULCC Hold
- OCUL Strong Buy
- Analyst Count
- ULCC 11
- OCUL 8
- Target Price
- ULCC $6.35
- OCUL $16.50
- AVG Volume (30 Days)
- ULCC 2.6M
- OCUL 929.4K
- Earning Date
- ULCC 10-29-2024
- OCUL 11-14-2024
- Dividend Yield
- ULCC N/A
- OCUL N/A
- EPS Growth
- ULCC N/A
- OCUL N/A
- EPS
- ULCC N/A
- OCUL N/A
- Revenue
- ULCC $3,664,000,000.00
- OCUL $61,442,000.00
- Revenue This Year
- ULCC $6.19
- OCUL $15.49
- Revenue Next Year
- ULCC $14.64
- OCUL $13.31
- P/E Ratio
- ULCC N/A
- OCUL N/A
- Revenue Growth
- ULCC 1.66
- OCUL 6.45
- 52 Week Low
- ULCC $2.79
- OCUL $2.15
- 52 Week High
- ULCC $8.33
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- ULCC 41.46
- OCUL 31.56
- Support Level
- ULCC $5.12
- OCUL $8.51
- Resistance Level
- ULCC $6.96
- OCUL $8.99
- Average True Range (ATR)
- ULCC 0.42
- OCUL 0.60
- MACD
- ULCC -0.17
- OCUL -0.30
- Stochastic Oscillator
- ULCC 20.57
- OCUL 10.20
About ULCC Frontier Group Holdings Inc.
Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.